Methods of neurodevelopmental assessment in children with neurodegenerative disease: Sanfilippo syndrome

JIMD Reports

Volumn 13, Issue , 2014, Pages 129-137

  Delaney, Kathleen A ^a,d   Rudser, Kyle R ^b   Yund, Brianna D ^a   Whitley, Chester B ^a   Haslett, Patrick A J ^c   Shapiro, Elsa G ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c SHIRE   (United States)

^d NONE   (United States)

Author keywords

Developmental quotient; Impaired child; Lysosomal storage disease; Standard score; Vineland adaptive behavior

Indexed keywords

EID: 84941424766     PISSN: 21928304     EISSN: 21928312     Source Type: Book Series    
DOI: 10.1007/8904_2013_269     Document Type: Chapter

References (36)

1. Baehner F, Schmiedeskamp C, Krummenauer F et al (2005) Cumulative incidence rates of the mucopolysaccharidoses in Germany. J Inherit Metab Dis 28:1011–1017
2. Bayley N (2006) Bayley scales of infant and toddler development– third edition. Psychological Corporation, San Antonio
3. Bjoraker K, Delaney K, Peters C et al (2006) Long term outcomes of adaptive functions for children with MPS I. J Beh Dev Peds 27:290–296
4. Bland JM, Altman DG (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 327:307–310
5. Cleary MA, Wraith JE (1993) Management of mucopolysaccharidosis type III. Arch Dis Child 69:403–406
6. Delaney K, Nestrasil I, Yund B et al (2013) Motor function decline and motor apraxia in Sanfilippo syndrome. Mol Genet Metab 108:S34
7. Elliott CD (2007) Differential ability scales-second edition. Psychological Corporation, San Antonio
8. Fraser J, Wraith JE, Delatycki MB (2002) Sleep disturbance in mucopolysaccharidosis type III (Sanfilippo syndrome): a survey of managing clinicians. Clin Genet 62:418–421
9. Heron B, Mikaeloff Y, Froissart R, et al (2011) Incidence and natural history of mucopolysaccharidosis type III in France and comparison with United Kingdom and Greece. Am J Med Genet A 155A:58–68
10. Hopwood J (2007) Sanfilippo syndrome: clinical genetic diagnosis and therapies. In: Barranger J (ed) Lysosomal storage disorders, Ch. 26. Springer, New York, pp 415–432
11. Huntley M (1996) The Griffiths mental development scales: from birth to 2 years, 2nd ed. The Test Agency Limited, Oxford
12. Kaufman AS, Kaufman NL (2004) Manual for the Kaufman assessment battery for children—second edition (KABC-II) comprehensive form. American Guidance Service, Circle Pines
13. Lawrence CW (1992) Assessing the use of age-equivalent scores in clinical management. Lang Speech Hear Serv Sch 23(1):6–8
14. Maloney ES, Larrivee LS (2007) Limitations of age-equivalent scores in reporting the results of norm-referenced tests. Contemporary Issues Commun Sci Disorder 34:86–93
15. Martin HR, Poe MD, Reinhartsen D, Pretzel RE, Roush J, Rosenberg A, Dusing SC, Escolar ML (2008) Methods for assessing neuro-development in lysosomal storage diseases and related disorders: a multidisciplinary perspective. Acta Pediat 97:69–75
16. Meikle PJ, Hopwood JJ, Clague AE, Carey WF (1999) Prevalence of lysosomal storage disorders. JAMA 281:249–254
17. Meyer A, Kossow K, Gal A et al (2007) Scoring evaluation of the natural course of mucopolysaccharidosis type IIIA (Sanfilippo syndrome type A). Pediatrics 120:e1255–e1261
18. Mullen EM (1995) Mullen scales of early learning. American Guidance Service, Circle Pines
19. Naglieri J, Goldstein S (2009) Practitioner’s to guide assessing intelligence and achievement. Wiley, Hoboken
20. Peters C, Balthazor M, Shapiro E et al (1996) Outcome of unrelated donor bone marrow transplantation in forty children with Hurler syndrome. Blood 87:4894–4902
21. Peters C, Shapiro E, Anderson J et al (1998) Hurler Syndrome: II. Outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. Blood 91:2601–2608
22. Poorthuis BJ, Wevers RA, Kleijer WJ et al (1999) The frequency of lysosomal storage diseases in The Netherlands. Hum Genet 105:151–156
23. Raggio DJ, Massingale TW, Bass JD (1994) Comparison of Vineland adaptive behavior scales-survey form age equivalent and standard score with the Bayley Mental Development Index. Percept Mot Skills 79:203–206
24. Roid GH (2003) Stanford-Binet intelligence scales (5th ed). Riverside, Itasca, NY
25. Roid GH, Miller LJ (1997) Leiter international performance scale-revised: examiner’s manual. Stoelting Co., Wood Dale
26. Shapiro E, Balthazor M. Metabolic (1999) and neurodegenerative disorders of childhood. In: G Taylor, D Ris, K Yeates (eds) Pediatric neuropsychology: research, theory and practice. Guil-ford Press, New York. pp 171–205
27. Shapiro E, Klein K (1993) Childhood dementia: neuropsychological assessment and treatment of degenerative childhood diseases. In: Tramontana MG, Hooper SR (eds) Advances in child neuropsychology, Volume III. Ch. 4. Springer, New York, pp 119–171
28. Shapiro EG, Lockman LA, Balthazor M, Krivit W (1995) Neuropsychological outcomes of several storage diseases with and without bone marrow transplantation. J Inherit Metab Dis 18:413–429
29. Sigelman CK, Rider EA (2011) Life-span human development – sixth edition. Wadsworth Cengage Learning, Belmont
30. Sparrow SS, Cicchetti DV, Balla DA (2005) Vineland adaptive behavior scales, 2nd edn. Psychological Corporation, San Antonio
31. Staba SL, Escolar ML, Poe M et al (2004) Cord blood transplants from unrelated donors in patients with Hurler's syndrome. NEJM 350:1060–1969
32. Valstar MJ, Marchal JP, Grootenhuis M et al (2011) Cognitive development in patients with mucopolysaccharidosis type III (Sanfilippo syndrome). Orphanet J Rare Dis 6:43
33. Volkmar FR, Sparrow SS, Goudreau D, Cicchetti DV, Paul R, Cohen DJ (1987) Social deficits in autism: an operational approach using the Vineland Adaptive Behavior Scales. J Amer Acad Child Psychiat 26:156–165
34. Wechsler D (2002) Wechsler preschool and primary scale of intelligence, 3rd edn. Psychological Corporation, San Antonio
35. Wraith JE, Beck M, Lane R et al (2007) Enzyme replacement therapy for mucopolysaccharidosis I patients less than 5 years old: Results of a multinational study of recombinant human alpha-L-iduonidase (laronidase). Pediatrics 120:e37–e46
36. Ziegler R, Shapiro E (2010) Metabolic neurodegenerative diseases across the lifespan. In: Donders J, Hunter S (eds) Principles and practice of lifespan developmental neuropsychology, ch. 15. Cambridge University Press, Cambridge, pp 427–448